Bausch + Lomb Corp. Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering

By Staff
Friday, January 14, 2022 8:45 AM LAVAL, Quebec and VAUGHAN, Ontario—Bausch Health Companies Inc. (NYSE/TSX: BHC) said late Thursday that it has filed with the Securities and Exchange Commission (SEC) its plans for spinning off the wholly owned subsidiary Bausch + Lomb Corp. This filing is in connection with the company’s previously announced intention to separate the vision care business, Bausch + Lomb Corp. and the plan now moves ahead with the public filing of a registration statement on Form S-1 with the SEC and a preliminary base post-receipt pricing procedure (PREP) prospectus with the securities regulatory authorities in each of the provinces and territories of Canada (other than Quebec) relating to this proposed initial public offering (IPO) of Bausch + Lomb's common shares.

Staar Surgical Posts Preliminary Fourth Quarter Net Sales of Approximately $59 Million

By Staff
Friday, January 14, 2022 12:21 AM LAKE FOREST, Calif.—Staar Surgical Company (NASDAQ: STAA) posted preliminary results for the fourth quarter and fiscal year ended Dec. 31, 2021.

Despite Difficult Supply Chain, Kits Says it Delivered a Record Number of Eyeglass Orders in 2021

By Staff
Friday, January 14, 2022 12:18 AM VANCOUVER—Kits Eyecare Ltd. (TSX: KITS), a vertically integrated, digital eyecare platform based here, said this week that in last year’s fourth quarter it delivered 50,000 eyeglasses to patients, and 156,000 total eyecare orders to patients.

Alcon Completes Acquisition of Glaucoma Surgery (MIGS) Device Maker Ivantis

By Staff
Tuesday, January 11, 2022 12:21 AM GENEVA—Alcon (SIX/NYSE: ALC) yesterday announced the closing of its previously announced acquisition of Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.

Advancing Eyecare Acquires Santinelli International

By Staff
Wednesday, January 5, 2022 7:30 AM JACKSONVILLE, Fla.—Advancing Eyecare, a leading North American provider of ophthalmic instruments and portfolio company of Atlantic Street Capital (ASC), announced today the acquisition of Santinelli International, a leading, award-winning supplier of optical finishing equipment. Details of the transaction, which closed in December 2021, were not disclosed. Advancing Eyecare is currently comprised of Lombart Instrument, Marco Ophthalmic, INNOVA Medical, S4Optik, Santinelli International and other top brands. Its combined scope offers “the broadest product portfolio, the most knowledgeable people, and the most reliable service in the industry,” the company said in a statement.

EssilorLuxottica and GrandVision Agree to Sell Stores in The Netherlands and Belgium to MPG Austria’s ORIG BENE Group

By Staff
Tuesday, December 28, 2021 12:24 AM CHARENTON-LE-PONT, France and SCHIPHOL, the Netherlands—EssilorLuxottica, GrandVision and the Optic Retail International Group BENE, a member of MPG Austria (ORIG/MPG), announced late last week that they have entered into an agreement for ORIG/MPG to acquire 142 EyeWish stores in the Netherlands and 35 GrandOptical stores in Belgium. This follows the commitments agreed upon with the European Commission on March 23, 2021, as part of the acquisition of GrandVision by EssilorLuxottica, the announcement noted.

EssilorLuxottica Reports Employee Shareholding Plan Hits New High With Coverage in 78 Countries

By Staff
Monday, December 27, 2021 12:21 AM CHARENTON-LE-PONT, France—EssilorLuxottica (Reuters: ESLX.PA) said last week that results from its “Boost 2021” international employee shareholding plan show that close to 54,000 eligible employees subscribed in 78 countries, with a very high subscription rate above 65 percent compared with 62 percent last year.

EssilorLuxottica Announces Final Results of its Public Offer for GrandVision Shares

By Staff
Thursday, December 23, 2021 12:24 AM CHARENTON-LE-PONT, France and SCHIPHOL, the Netherlands—EssilorLuxottica and GrandVision this week announced the results of the post-acceptance period for GrandVision shares that ended Dec. 20. During the post-acceptance period, 268,744 GrandVision shares have been tendered under the offer, representing an interest of approximately 0.11 percent of the issued share capital of GrandVision, the announcement noted. Including the 99.73 percent interest already held by EssilorLuxottica, the acquiring company will hold a total of 254,031,577 GrandVision shares, representing approximately 99.84 percent of the issued share capital of GrandVision.

EssilorLuxottica and GrandVision Enter into an Agreement With Vision Group for the Sale of Stores in Italy

By Staff
Monday, December 20, 2021 12:18 AM CHARENTON-le-PONT, France, SCHIPHOL, The Netherlands and MILAN, Italy—EssilorLuxottica (Reuters: ESLX.PA), GrandVision (Euronext: GVNV) and Vision Group, one of the largest distribution networks for Italian opticians and a retail player under the VisionOttica banner, said Friday that the companies have entered into an agreement for Vision Group to acquire the VistaSì chain in Italy, including the brand and all the 99 stores, and 75 GrandVision stores in the country. This follows the commitments agreed upon with the European Commission on March 23, 2021, as part of the acquisition of GrandVision by EssilorLuxottica.

Kering Eyewear Opens New Subsidiary in Central Eastern Europe

By Staff
Monday, December 20, 2021 12:15 AM PADOVA, Italy—Kering Eyewear’s long-term investment strategy to develop its business in the Eastern Europe region continues with Europe, as the company confirmed the opening of a new subsidiary in Central Eastern Europe, with a new branch in the Czech Republic. The move follows the opening of its subsidiary in Croatia last February and signals the company's strong confidence in the potential of the region, the announcement said. The new office will be located in Brno, a city in the southeast of Czechia.

Tekcapital's Innovative Eyewear Files U.S. IPO Registration for its Lucyd Business

By Staff
Friday, December 17, 2021 12:18 AM LONDON—Tekcapital Plc (AIM: TEK, OTCQB: TEKCF) announced on Dec. 14 that Innovative Eyewear Inc., a U.S. subsidiary of its portfolio company Lucyd Ltd, filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC), for a proposed initial public offering of shares of its common stock in the U.S. Tekcapital currently owns 100 percent of the share capital of Lucyd Ltd and approximately 80 percent  of the share capital of Innovative Eyewear, Inc., an announcement said.

Zeiss Posts Record Earnings for Fiscal Year 2020/21

By Staff
Thursday, December 16, 2021 12:33 AM OBERKOCHEN, Germany—The Zeiss Group, based here, ended fiscal year 2020/21 ending Sept. 30, 2021 with €7.529 billion in revenue, the highest revenue in its 175-year history.

GrandVision Enters Agreement to Acquire Swedish Optical Retailer Smarteyes from Investor Group

By Staff
Thursday, December 16, 2021 12:24 AM SCHIPHOL, The Netherlands—GrandVision NV (Euronext: GVNV) said Wednesday that Sweden’s Synoptik Foundation and GrandVision have entered into an agreement with Mellby Gård AB to acquire the Swedish optical chain Smarteyes through the GrandVision subsidiary Synoptik A/S. The closing of the transaction is subject to customary regulatory approvals, according to the announcement. The financial terms of the deal have not been disclosed. Smarteyes was founded in 2007 and by the end of 2020 operated 87 stores. The stores are located in Sweden (65 stores), Denmark (12 stores) and Germany (10 stores).

EssilorLuxottica Anticipates Delisting of GrandVision by Jan. 10, 2022

By Staff
Tuesday, December 14, 2021 12:15 AM CHARENTON-LE-PONT, France and SCHIPHOL, the Netherlands—EssilorLuxottica and GrandVision N.V. jointly announced yesterday that, considering that EssilorLuxottica now holds more than 95 percent of the issued and outstanding shares in GrandVision, Euronext approved the delisting of the shares from Euronext Amsterdam. In consultation with Euronext, the companies said it has been decided that delisting will take place on Jan. 10, 2022 and the last trading day of the shares will therefore be Jan. 7, 2022. They noted that terms not defined in the press release will have the meaning as set out in the offer memorandum.

Carl Zeiss Meditec Reports Record Revenue in Fiscal 2020-21 as Group Looks Ahead to 2022 With 'Some Optimism'

By Staff
Monday, December 13, 2021 12:24 AM JENA, Germany—Carl Zeiss Meditec (ISIN: DE 0005313704) reported late last week that it generated revenue of approximately €1,647 million in fiscal year 2020-21, which represents growth of 23.3 percent compared with the prior fiscal year’s revenue of €1,336 million. The percentage increase adjusted for currency effects was 26.5 percent, according to the announcement. Revenue in the Americas region increased 16.9 percent to €449 million (prior year: €384 million) due to “the further acceleration of the U.S. business,” the announcement noted.